Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology

Agergaard, 2022, Characteristics of a Danish Post COVID Cohort referred for examination due to persistent symptoms six months after mild acute COVID-19, J Clin Med, 11, 7338, 10.3390/jcm11247338 Agergaard, 2021, Myopathic changes in patients with long-term fatigue after COVID-19, Clin Neurophysiol, 132, 1974, 10.1016/j.clinph.2021.04.009 Albaba, 2021, Incidence, risk factors, and outcomes of rhabdomyolysis in hospitalized patients with COVID-19 infection, Cureus., 13, e19802 Aschman, 2021, Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died, JAMA Neurol, 78, 948, 10.1001/jamaneurol.2021.2004 Augustin, 2021, Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study, Lancet Reg Health Eur, 6 Buttery, 2021, Patient symptoms and experience following COVID-19: results from a UK-wide survey, BMJ Open Respir Res, 8, 10.1136/bmjresp-2021-001075 Chen, 2022, Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or Long COVID: a meta-analysis and systematic review, J Infect Dis, 226, 1593, 10.1093/infdis/jiac136 ClinicalTrials.gov. Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection; 2022. https://clinicaltrials.gov/ct2/show/NCT05152849. Davis, 2021, Characterizing long COVID in an international cohort: 7 months of symptoms and their impact, EClinicalMedicine, 38, 10.1016/j.eclinm.2021.101019 Groff, 2021, Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review, JAMA Netw Open, 4, e2128568, 10.1001/jamanetworkopen.2021.28568 Hansen, 2022, High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial, Lancet Reg Health Eur, 100539 Haykal, 2022, The Clinical Neurophysiology of COVID-19- Direct Infection, Long-Term Sequelae and Para-Immunization responses: a literature review, Clin Neurophysiol Pract, 8, 3, 10.1016/j.cnp.2022.09.005 Hejbøl, 2022, Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology, Eur J Neurol, 29, 2832, 10.1111/ene.15435 Huang, 2021, 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study, Lancet, 398, 747, 10.1016/S0140-6736(21)01755-4 Kanberg, 2021, Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up, EBioMedicine, 70, 10.1016/j.ebiom.2021.103512 Kaspersen, 2021, Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020, Int J Infect Dis, 109, 17, 10.1016/j.ijid.2021.06.017 Kumar A, Narayan RK, Kumar S, Pareek V, Kumari C, Jha RK et al. NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells. bioRxiv 2022.01.19.476893 2022. Li, 2021, Viral infection modulates mitochondrial function, Int J Mol Sci, 22 Lopez-Leon, 2021, More than 50 long-term effects of COVID-19: a systematic review and meta-analysis, Sci Rep, 11, 16144, 10.1038/s41598-021-95565-8 Malas, 2020, Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis, EClinicalMedicine., 29 Mehandru, 2022, Pathological sequelae of long-haul COVID, Nat Immunol, 23, 194, 10.1038/s41590-021-01104-y Mølhave, 2021, Long-Term Symptoms among Hospitalized COVID-19 Patients 48 Weeks after Discharge-A Prospective Cohort Study, J Clin Med, 10 Nasserie, 2021, Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review, JAMA Netw Open, 4, e2111417, 10.1001/jamanetworkopen.2021.11417 Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 6 October 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/latest. Ortelli, 2022, Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19, Eur J Neurol, 29, 1652, 10.1111/ene.15278 Paul, 2021, Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome, Proc Natl Acad Sci USA, 118 Pelà, 2022, Sex-Related Differences in Long-COVID-19 Syndrome, J. Womens Health (Larchmt., ) 31, 620, 10.1089/jwh.2021.0411 Pilotto, 2021, SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses, Clin Infect Dis, 73, e3019, 10.1093/cid/ciaa1933 Sanders, 2019, Guidelines for single fiber EMG, Clin Neurophysiol, 130, 1417, 10.1016/j.clinph.2019.04.005 Shi, 2021, Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers, JAMA Intern Med, 181, 122, 10.1001/jamainternmed.2020.6278 Singh, 2022, Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing, Chest, 161, 54, 10.1016/j.chest.2021.08.010 Stålberg, 2016, Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study, Muscle Nerve, 53, 351, 10.1002/mus.24750 Stålberg, 2019, Standards for quantification of EMG and neurography, Clin Neurophysiol, 130, 1688, 10.1016/j.clinph.2019.05.008 Syddansk Universitet, Statens Institut for Folkesundhed Sundhedsstyrelsen. Danskernes Sundhed. Tal fra Den Nationale Sundhedsprofil; 2021. https://www.danskernessundhed.dk/. Taquet, 2021, Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19, PLoS Med, 18, e1003773, 10.1371/journal.pmed.1003773 Taquet, 2021, 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records, Lancet Psychiatry, 8, 416, 10.1016/S2215-0366(21)00084-5 Versace, 2021, Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19, Clin Neurophysiol, 132, 1138, 10.1016/j.clinph.2021.03.001 Whitaker, 2022, Persistent COVID-19 symptoms in a community study of 606,434 people in England, Nat Commun, 13, 1957, 10.1038/s41467-022-29521-z WHO. At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; 2022. https://www.who.int/europe/news/item/13-09-2022-at-least-17-million-people-in-the-who-european-region-experienced-long-covid-in-the-first-two-years-of-the-pandemic--millions-may-have-to-live-with-it-for-years-to-come. Xie, 2021, Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status, Nat Commun, 12, 6571, 10.1038/s41467-021-26513-3 Zambelis, 2021, Reference values for voluntary SFEMG jitter in orbicularis oculi, frontalis, extensor digitorum communis and tibialis anterior using a concentric needle electrode, Neurophysiol Clin, 51, 387, 10.1016/j.neucli.2021.01.002 ZOE Health Study. How long does COVID-19 last? 2022. https://covid.joinzoe.com/post/covid-long-term.